Cargando…
Effectiveness and tolerability of guselkumab in patients with psoriasis: A longitudinal Belgian retrospective multicenter study
Autores principales: | Ghislain, Pierre-Dominique, Failla, Valérie, Lambert, Jo, Soenen, Rani, Grine, Lynda, Tannous, Julio, Guiot, Françoise, Willaert, Fabienne, Fierens, Hugues, Vandaele, Mark, Boonen, Hugo, Saerens, Julie, Meuleman, Véronique, Stockman, Annelies, Belpaire, Arno, Swimberghe, Sandra, Temmerman, Linda, Dekeyser, Sam, Lambert, Jean-Michel, de Schaetzen, Virginie, de la Brassinne, Michel, Benhadou, Farida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362316/ https://www.ncbi.nlm.nih.gov/pubmed/34409384 http://dx.doi.org/10.1016/j.jdin.2021.05.001 |
Ejemplares similares
-
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
por: Grine, L., et al.
Publicado: (2020) -
Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 2)
por: Lambert, J.L.W., et al.
Publicado: (2020) -
Guselkumab for plaque psoriasis
Publicado: (2019) -
Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 1)
por: Lambert, J.L.W., et al.
Publicado: (2020) -
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis
por: Soenen, Rani, et al.
Publicado: (2022)